TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of cases detected per 1,000 people
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: neurobiological predictors of response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular Endothelial Function (Flow-Mediated Dilation [FMD])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Proportion of patients requiring a rescue opioid prescription
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average total morphine milligram equivalents (MME) consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Magnitude of Pendelluft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Magnitude of Pendelluft during inspiratory pause
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Magnitude of respiratory effort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to maximum plasma concentration observed (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of microRNA30a in blood sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Post-auricular and frontal BIS values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who received information about addictive disorders
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients identified with an addictive disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss during the procedure expressed as a decrease in hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood loss volume during the procedure expressed in volume units
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Conversion rate from hysteroscopy to laparoscopy or laparotomy due to hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Difference in serum renin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sepsis convalescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean potassium difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time spent in PACU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: CPIS Clinical Pulmonary Infection Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: GKS Glasgow Coma Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Eye Movement Biomarkers (EMB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervicovertebral angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perturbed Stance Postural Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased heart rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decreased inflammatory biomarker CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decreased perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Engagement with MOUD
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: 89Zr-trastuzumab PET imaging effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WOMAC-C Subscale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of mortality or dropout due to being too sick
Endpoint domain: Mortality/survival
Primary endpoint: EBA-TTP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle architecture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle viscoelastic properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive regard for the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Residual hepatic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of improvement in TNSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time Zero to the Time of the Last Sampling (AUC0-tlast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve from Time Zero to Infinity (AUC-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in Sino-nasal outcome test-22 (SNOT-22) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Task Completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Successfully Completed EHR Tasks
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Time to Case Completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of eyes with slit-lamp findings (Grade 3 or 4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CR rate at first evaluation post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in bone specific alkaline phosphatase (BSAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression-free survival (PFS) at 8 months
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy of budesonide MMX vs prednisolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete response (CR) proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: partial response (PR) proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Patients outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total score of e-health literacy scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Full Mouth Bleeding Score (FMBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GI symptoms assessed by CoMiSS®
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pre-test post-test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Variation of hourly urine output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Differences in resting state brain networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: knee joint range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lysholm knee function score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: level of coping with stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Skin texture (fair or smooth)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin pore size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Inflammatory skin thickness/hardness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Erythema color and area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Pressure Pain Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of HY1272
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics (PK) of HY1272
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot and ankle disability index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: In vivo pathology of serotonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clot wave form 1st derivative changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clot wave form 2nd derivative changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in delay phase, baseline, acceleration, deceleration and end point phases of CWA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Operative Death (POD)
Endpoint domain: Mortality/survival
Primary endpoint: Change in Test My Brain Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of Life Scale - Abbreviated
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Dysfunctional Attitudes Scale - Defeatist Beliefs Subscale (DAS-DB) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in alanine amino transferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Emotion-related trajectories
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Conversion of hsPDA to non-hsPDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically Stable Hemoglobin (Hb) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinically Stable Platelet Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinically Stable Liver Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically Stable Spleen Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sleep regularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in social jetlag
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transition time of oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers of the epithelial-mesenchymal transition process
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-dependent change in LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Width of the keratinized gingiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Thickness of the peri-implant soft tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of Participants with Solicited Local and Systemic Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of Escherichia coli resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to NEDA-3 failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 11-point Numerical Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of Agitation
Endpoint domain: Adverse events/effects
Primary endpoint: rate of cardiac-related death
Endpoint domain: Mortality/survival
Primary endpoint: TIGIT expression frequency on NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pupil diameter during SDTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete cow's milk tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: work difficulties
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: perceived needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Y-Check Screening outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO-5 Well-being Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Affected status of Familial Hypercholesterolemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image quality excellence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: temporal summation of second pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Neuromuscular Recovery Scale (PedsNRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Quality of Life Inventory CP Module (PedsQL-CP)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change scores of Modified Ashworth Scale (MAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose and/or recommended phase II dose
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in soft tissue height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body growth parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-hospital mortality for all causes
Endpoint domain: Mortality/survival
Primary endpoint: ureter stone free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from baseline in blood lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in blood coagulation factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in arteriosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Allergic Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Clinician Administered PTSD Scale - 5 (CAPS-5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence and severity of dose limiting toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: 4-month adherence rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Biochemical markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uric acid / high density lipoprotein cholesterol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: monocyte / high density lipoprotein ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from Baseline in eGFR at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Freedom from a composite of Major adverse events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Quality of Life Alzheimer's Disease (QOL-AD)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in 12-Item Zarit Burden Interview (ZBI-12)
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Changes in Health Care Utilization survey
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of Participants with Lower Systolic and/or Diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Using Antihypertensive Therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fecal microbiome characterization at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal microbiome characterization at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of target force maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of viral load at 36 months follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change of CD4 counts at 36 months follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in mean postprandial appetite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee society score (KSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Selumetinib area under the plasma concentration-time curve from zero to 12 hours post-dose (AUC0-12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastrointestinal Adverse Events graded by CTCAE Ver 5.0 (Grade 1 to 5)
Endpoint domain: Adverse events/effects
Primary endpoint: Assessing change of Gastrointestinal toxicity diary: Modified Bristol Stool Form Scale for Children (mBSFS-C)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Delirium screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the seating system of the user's wheelchair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glucose disposition index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Parent Acceptance/Warmth during parent-child interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coparenting Quality:mother-father pleasure in coparenting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coparenting Relationship Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement in pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 24 hour change in insulin sensitivity (Oral glucose insulin sensitivity index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24 hour change in insulin sensitivity (Matsuda index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sense of Competence in Dementia Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Any documented atrial arrhythmia episode lasting for at least 30 s
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Response rate to panobinostat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strain-level stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With ITCH4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence rate of dose-limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: pain level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Oxford Ankle Foot Questionnaire for Children (OxAFQ-C)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Regression rate of gastric intestinal metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Progression rate of gastric intestinal metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Subcortical Volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tolerability and safety of the FES for MDD
Endpoint domain: Adverse events/effects
Primary endpoint: Caregiver Self-Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Autonomic Reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and Negative Syndrome Scale for Schizophrenia (PANSS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multiple Sclerosis Work Instability Scale (MS-WIS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Psychological Flexibility - Multi-dimensional Psychological Flexibility Inventory (MPFI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Resilience - Connor-Davidson Resilience Scale (CD-RISC 10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-efficacy - Unidimensional Self-efficacy scale for Multiple Sclerosis (USE-MS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RALPH interview guide score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HOMA ir
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative time to discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of subjects with static stiffness index SSI ≥ 10 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volumetric analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGM-measured time in range (TIR, 70-180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes